A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

The deal returns the drug-maker to the growing market for obesity drugs after scrapping an experimental weight-loss pill.

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

GLP-1 drugs are reshaping our bodies, but also our society. They may even help to treat major diseases once thought incurable ...

Eli Lilly plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the ...

Patients taking a daily weight-loss pill lost up to 12% of their body weight in a global trial, according to the Cornell ...

We are undertaking that process now and I would expect we’ll have a lot to say about that come December in my budget speech,” ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

By Andrew Silver SHANGHAI (Reuters) -Innovent Biologics' newly launched weight-loss drug is making inroads in its home market ...

Tennis goat Serena Williams has been on a losing streak since she hung up her racket three years ago – the 23-time Grand Slam winner has shed 31 pounds with the help of the weight-loss drug Zepbound, ...